| Primary Identifier | IPR009120 | Type | Family |
| Short Name | BACE1 |
| description | The beta-site APP cleaving enzyme-1 (BACE1), also known as Aspartyl protease 2 and memapsin-2, mediates one of the two proteolytic cleavages of beta-amyloid precursor protein (APP) to yield the amyloid β-peptide (Abeta), a key pathogenic agent in Alzheimer's disease (AD) []. Axonal and Schwann cell BACE1 is also required for remyelination of injured nerves []. BACE1 inhibitor drugs have been evaluated for AD treatment []. BACE1 is () and MEROPS identifier A01.004. |
